{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:08:48Z","timestamp":1793657328090,"version":"4.5.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"The Horizons Research Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Staphylococcus aureus bacteremia (SAB) is uniquely characterized by focal pyogenic complications that might not be apparent clinically. We investigated the benefit of adding fluorodeoxyglucose\u2013positron emission tomography\/computed tomography (FDG-PET\/CT) in the workup of patients with SAB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a matched-cohort study patients with SAB (intervention group) were prospectively recruited to undergo FDG-PET\/CT 7\u201314 days after diagnosis. Treatment was directed by FDG-PET\/CT findings. Clinical outcomes were compared with a control group of patients with SAB who had not undergone FDG-PET\/CT, matched by age, Charlson score, methicillin susceptibility, and survival duration to FDG-PET\/CT. The primary outcome was 90-day mortality. Residual confounding was controlled through regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the study period 149 patients with 151 separate episodes of SAB underwent FDG-PET\/CT and were compared with 150 matched patients with 151 SAB episodes. Patients in the intervention group acquired infections more frequently in the community and had less frequently solid malignancies and more frequently high-risk SAB. Ninety-day mortality in the intervention group was significantly lower than in the control group (21\/151 [13.9%] vs 43\/151 [28.5%], P\u2005=\u2005.002). The difference remained significant in a subgroup analysis of patients with community-onset infections without malignancy and among patients with low-risk SAB. Controlling for other risk factors for mortality, FDG-PET\/CT performance among all patients was independently associated with lower mortality (OR, .39; 95% CI, .18\u2013.84). Patients in the intervention group had longer duration of treatment and more focus control procedures performed compared with the control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FDG-PET\/CT in patients with SAB seems to improve survival through guidance of treatment duration and co-interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaa929","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T15:11:01Z","timestamp":1593616261000},"page":"e3859-e3866","source":"Crossref","is-referenced-by-count":47,"title":["Integration of FDG-PET\/CT in the Diagnostic Workup for\n                    <i>Staphylococcus aureus<\/i>\n                    Bacteremia: A Prospective Interventional Matched-cohort Study"],"prefix":"10.1093","volume":"73","author":[{"given":"Nesrin","family":"Ghanem-Zoubi","sequence":"first","affiliation":[{"name":"Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kagna","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad","family":"Abu-Elhija","sequence":"additional","affiliation":[{"name":"Internal Medicine Department E, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Mustafa-Hellou","sequence":"additional","affiliation":[{"name":"Internal Medicine Department E, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majd","family":"Qasum","sequence":"additional","affiliation":[{"name":"Internal Medicine Department D, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Keidar","sequence":"additional","affiliation":[{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel"},{"name":"Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"2021121011163506100_CIT0001","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021121011163506100_CIT0002","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021121011163506100_CIT0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021121011163506100_CIT0004","first-page":"362","article-title":"Predictors of mortality in staphylococcus aureus bacteremia","volume-title":"Clin Microbiol Rev","author":"van Hal","year":"2012"},{"key":"2021121011163506100_CIT0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jinf.2018.08.015","article-title":"Survival following Staphylococcus aureus bloodstream infection: a prospective multinational cohort study assessing the impact of place of care","volume":"77","author":"Nambiar","year":"2018","journal-title":"J Infect"},{"key":"2021121011163506100_CIT0006","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2967\/jnumed.109.072371","article-title":"18F-FDG PET\/CT for detection of metastatic infection in gram-positive bacteremia","volume":"51","author":"Vos","year":"2010","journal-title":"J Nucl Med"},{"key":"2021121011163506100_CIT0007","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2967\/jnumed.117.191981","article-title":"18F-FDG PET\/CT optimizes treatment in staphylococcus aureus bacteremia and is associated with reduced mortality","volume":"58","author":"Berrevoets","year":"2017","journal-title":"J Nucl Med"},{"key":"2021121011163506100_CIT0008","first-page":"1351","article-title":"Clinical value of FDG-PET\/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus","volume-title":"Eur J Nucl Med Mol Imaging","author":"Br\u00f8ndserud","year":"2019"},{"key":"2021121011163506100_CIT0009","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jiac.2019.04.016","article-title":"Mortality in patients with high risk Staphylococcus aureus bacteremia undergoing or not PET-CT: a single center experience","volume":"25","author":"Yildiz","year":"2019","journal-title":"J Infect Chemother"},{"key":"2021121011163506100_CIT0010","first-page":"3036","article-title":"The 2015 ESC guidelines for the management of infective endocarditis","volume":"36","author":"Habib","year":"2015","journal-title":"Eur. Heart J"},{"key":"2021121011163506100_CIT0011","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"2021121011163506100_CIT0012","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021121011163506100_CIT0013","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejvs.2018.07.010","article-title":"Diagnostic imaging in vascular graft infection: a systematic review and meta-analysis","volume":"56","author":"Reinders Folmer","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2021121011163506100_CIT0014","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"2021121011163506100_CIT0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MD.0b013e31824d7ed2","article-title":"Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia","volume":"91","author":"Vos","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"2021121011163506100_CIT0016","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2967\/jnumed.118.221929","article-title":"18F-FDG PET\/CT-Guided treatment duration in patients with high-risk Staphylococcus aureus bacteremia: a proof of principle","volume":"60","author":"Berrevoets","year":"2019","journal-title":"J Nucl Med"},{"key":"2021121011163506100_CIT0017","first-page":"22","article-title":"National costs associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010\u20132014","volume":"68","author":"Klein","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021121011163506100_CIT0018","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2967\/jnumed.111.089714","article-title":"Cost-effectiveness of routine (18)F-FDG PET\/CT in high-risk patients with gram-positive bacteremia","volume":"52","author":"Vos","year":"2011","journal-title":"J Nucl Med"},{"key":"2021121011163506100_CIT0019","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1473-3099(10)70285-1","article-title":"Clinical management of Staphylococcus aureus bacteraemia","volume":"11","author":"Thwaites","year":"2011","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa929\/33727872\/ciaa929.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/73\/11\/e3859\/41607697\/ciaa929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/73\/11\/e3859\/41607697\/ciaa929.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T06:28:56Z","timestamp":1639117736000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/11\/e3859\/5868894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,7,8]]},"published-print":{"date-parts":[[2021,12,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa929","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2020,7,8]]}}}